Study of Tamibarotene in Patients With ADPKD
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Rege Nephro Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT06289998
- Locations
- π―π΅
Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan
π―π΅Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan
π―π΅Kurume University Hospital, Kurume, Fukuoka, Japan
Β© Copyright 2024. All Rights Reserved by MedPath